Copyright Reports & Markets. All rights reserved.

Global At-Home Drug of Abuse Market Professional Survey Report 2019

Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on At-Home Drug of Abuse Industry
  • 1.7 COVID-19 Impact: At-Home Drug of Abuse Market Trends
  • 2 Global At-Home Drug of Abuse Quarterly Market Size Analysis

    • 2.1 At-Home Drug of Abuse Business Impact Assessment - COVID-19
      • 2.1.1 Global At-Home Drug of Abuse Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global At-Home Drug of Abuse Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global At-Home Drug of Abuse Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global At-Home Drug of Abuse Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global At-Home Drug of Abuse Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers At-Home Drug of Abuse Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into At-Home Drug of Abuse Market
    • 3.5 Key Manufacturers At-Home Drug of Abuse Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on At-Home Drug of Abuse Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Consumable
      • 1.4.2 Equipment
    • 4.2 By Type, Global At-Home Drug of Abuse Market Size, 2019-2021
      • 4.2.1 By Type, Global At-Home Drug of Abuse Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global At-Home Drug of Abuse Price, 2020-2021

    5 Impact of Covid-19 on At-Home Drug of Abuse Segments, By Application

    • 5.1 Overview
      • 5.5.1 Urine
      • 5.5.2 Saliva
      • 5.5.3 Hair
      • 5.5.4 Others
    • 5.2 By Application, Global At-Home Drug of Abuse Market Size, 2019-2021
      • 5.2.1 By Application, Global At-Home Drug of Abuse Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global At-Home Drug of Abuse Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Siemens AG
      • 7.1.1 Siemens AG Business Overview
      • 7.1.2 Siemens AG At-Home Drug of Abuse Quarterly Production and Revenue, 2020
      • 7.1.3 Siemens AG At-Home Drug of Abuse Product Introduction
      • 7.1.4 Siemens AG Response to COVID-19 and Related Developments
    • 7.2 Danaher Corporation
      • 7.2.1 Danaher Corporation Business Overview
      • 7.2.2 Danaher Corporation At-Home Drug of Abuse Quarterly Production and Revenue, 2020
      • 7.2.3 Danaher Corporation At-Home Drug of Abuse Product Introduction
      • 7.2.4 Danaher Corporation Response to COVID-19 and Related Developments
    • 7.3 Shimadzu Corporation
      • 7.3.1 Shimadzu Corporation Business Overview
      • 7.3.2 Shimadzu Corporation At-Home Drug of Abuse Quarterly Production and Revenue, 2020
      • 7.3.3 Shimadzu Corporation At-Home Drug of Abuse Product Introduction
      • 7.3.4 Shimadzu Corporation Response to COVID-19 and Related Developments
    • 7.4 MilliporeSigma
      • 7.4.1 MilliporeSigma Business Overview
      • 7.4.2 MilliporeSigma At-Home Drug of Abuse Quarterly Production and Revenue, 2020
      • 7.4.3 MilliporeSigma At-Home Drug of Abuse Product Introduction
      • 7.4.4 MilliporeSigma Response to COVID-19 and Related Developments
    • 7.5 Drägerwerk
      • 7.5.1 Drägerwerk Business Overview
      • 7.5.2 Drägerwerk At-Home Drug of Abuse Quarterly Production and Revenue, 2020
      • 7.5.3 Drägerwerk At-Home Drug of Abuse Product Introduction
      • 7.5.4 Drägerwerk Response to COVID-19 and Related Developments
    • 7.6 Express Diagnostics
      • 7.6.1 Express Diagnostics Business Overview
      • 7.6.2 Express Diagnostics At-Home Drug of Abuse Quarterly Production and Revenue, 2020
      • 7.6.3 Express Diagnostics At-Home Drug of Abuse Product Introduction
      • 7.6.4 Express Diagnostics Response to COVID-19 and Related Developments
    • 7.7 Psychemedics Corporation
      • 7.7.1 Psychemedics Corporation Business Overview
      • 7.7.2 Psychemedics Corporation At-Home Drug of Abuse Quarterly Production and Revenue, 2020
      • 7.7.3 Psychemedics Corporation At-Home Drug of Abuse Product Introduction
      • 7.7.4 Psychemedics Corporation Response to COVID-19 and Related Developments
    • 7.8 Waters Corporation
      • 7.8.1 Waters Corporation Business Overview
      • 7.8.2 Waters Corporation At-Home Drug of Abuse Quarterly Production and Revenue, 2020
      • 7.8.3 Waters Corporation At-Home Drug of Abuse Product Introduction
      • 7.8.4 Waters Corporation Response to COVID-19 and Related Developments
    • 7.9 BioMerieux
      • 7.9.1 BioMerieux Business Overview
      • 7.9.2 BioMerieux At-Home Drug of Abuse Quarterly Production and Revenue, 2020
      • 7.9.3 BioMerieux At-Home Drug of Abuse Product Introduction
      • 7.9.4 BioMerieux Response to COVID-19 and Related Developments
    • 7.10 Roche
      • 7.10.1 Roche Business Overview
      • 7.10.2 Roche At-Home Drug of Abuse Quarterly Production and Revenue, 2020
      • 7.10.3 Roche At-Home Drug of Abuse Product Introduction
      • 7.10.4 Roche Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 At-Home Drug of Abuse Supply Chain Analysis
      • 8.1.1 At-Home Drug of Abuse Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on At-Home Drug of Abuse Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 At-Home Drug of Abuse Distribution Channels
      • 8.2.2 Covid-19 Impact on At-Home Drug of Abuse Distribution Channels
      • 8.2.3 At-Home Drug of Abuse Distributors
    • 8.3 At-Home Drug of Abuse Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      This report covers market size and forecasts of At-Home Drug of Abuse, including the following market information:
      Global At-Home Drug of Abuse Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global At-Home Drug of Abuse Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global At-Home Drug of Abuse Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global At-Home Drug of Abuse Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

      Key market players
      Major competitors identified in this market include Siemens AG, Danaher Corporation, Shimadzu Corporation, MilliporeSigma, Drägerwerk, Express Diagnostics, Psychemedics Corporation, Waters Corporation, BioMerieux, Roche, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Consumable
      Equipment

      Based on the Application:
      Urine
      Saliva
      Hair
      Others

      Buy now